Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Chi V Dang
Affiliation
Johns Hopkins University School of Medicine
ORCID
Career Start Year
1978
Papers
319
H Index
101
Expertise
CM4AI Collaborator
Prashant Mali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37883720
Pathways Involved in the Effect of Eflornithine in Neuroblastoma.
J Clin Oncol
2024
37883720
Pathways Involved in the Effect of Eflornithine in Neuroblastoma.
J Clin Oncol
2024
36658424
Time to hit pause on mitochondria-targeting cancer therapies.
Nat Med
2023
37553212
Cancer Metabolism Historical Perspectives: A Chronicle of Controversies and Consensus.
Cold Spring Harb Perspect Med
2023
36711638
MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis.
bioRxiv
2023
36865273
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.
bioRxiv
2023
36658424
Time to hit pause on mitochondria-targeting cancer therapies.
Nat Med
2023
37553212
Cancer Metabolism Historical Perspectives: A Chronicle of Controversies and Consensus.
Cold Spring Harb Perspect Med
2023
36711638
MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis.
bioRxiv
2023
36865273
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.
bioRxiv
2023
34862480
Targeting cancer metabolism in the era of precision oncology.
Nat Rev Drug Discov
2022
36083892
The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer.
Sci Immunol
2022
35373287
Peer Review: Value Added and Civility.
Cancer Res
2022
35487571
Translational Cancer Research Priorities and the Role of Molecular Imaging: A Conversation Between Chi Van Dang, Elizabeth Jaffee, and David Mankoff.
J Nucl Med
2022
36325690
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Mol Cancer Ther
2022
36325685
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Mol Cancer Res
2022
36261012
Circadian lncRNA ADIRF-AS1 binds PBAF and regulates renal clear cell tumorigenesis.
Cell Rep
2022
36321306
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Cancer Discov
2022
36321301
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Cancer Epidemiol Biomarkers Prev
2022
36321298
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Cancer Immunol Res
2022
36321294
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Blood Cancer Discov
2022
36321264
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Cancer Res
2022
36380966
Na<sup>+</sup>/H<sup>+</sup>-exchanger 1 enhances antitumor activity of engineered NK-92 natural killer cells.
Cancer Res Commun
2022
36317374
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Clin Cancer Res
2022
36317369
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Cancer Prev Res (Phila)
2022
35315913
Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer.
Cancer Res
2022
34862480
Targeting cancer metabolism in the era of precision oncology.
Nat Rev Drug Discov
2022
35373287
Peer Review: Value Added and Civility.
Cancer Res
2022
35487571
Translational Cancer Research Priorities and the Role of Molecular Imaging: A Conversation Between Chi Van Dang, Elizabeth Jaffee, and David Mankoff.
J Nucl Med
2022
36380966
Na<sup>+</sup>/H<sup>+</sup>-exchanger 1 enhances antitumor activity of engineered NK-92 natural killer cells.
Cancer Res Commun
2022
36325690
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Mol Cancer Ther
2022
36325685
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Mol Cancer Res
2022
36261012
Circadian lncRNA ADIRF-AS1 binds PBAF and regulates renal clear cell tumorigenesis.
Cell Rep
2022
36321306
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Cancer Discov
2022
36321301
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Cancer Epidemiol Biomarkers Prev
2022
36321298
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Cancer Immunol Res
2022
36321294
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Blood Cancer Discov
2022
36321264
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Cancer Res
2022
36083892
The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer.
Sci Immunol
2022
36317374
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Clin Cancer Res
2022
36317369
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Cancer Prev Res (Phila)
2022
35315913
Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer.
Cancer Res
2022
33482124
Cancer Moonshot 2.0.
Lancet Oncol
2021
34019293
Measuring MYC-Mediated Metabolism in Tumorigenesis.
Methods Mol Biol
2021
33482124
Cancer Moonshot 2.0.
Lancet Oncol
2021
33579708
Time-of-day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycle.
Sci Adv
2021
33509943
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers.
Cancer Res
2021
34085048
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma.
Nat Cancer
2021
34624215
Sex, life, and death in MYC-driven lymphomagenesis.
Mol Cell
2021
34853036
<i>Cancer Research</i> Celebrates the 50th Anniversary of the National Cancer Act and a Future of Hope.
Cancer Res
2021
1 - 50 of 638
Column Actions
Search
Recommended Authors
Amanda R Wasylishen
The University of Texas MD Anderson Cancer Center
Career Start Year
2008
Number of shared co-authors
3
Gabriel Leprivier
Institute of Neuropathology, Heinrich-Heine University Dusseldorf
Career Start Year
2006
Number of shared co-authors
1
Nicholas A Graham
University of Southern California
Career Start Year
2004
Number of shared co-authors
1
Heather R Christofk
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year
2004
Number of shared co-authors
1
Barak Rotblat
Ben-Gurion University of the Negev
Career Start Year
2002
Number of shared co-authors
0
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year
1999
Number of shared co-authors
4
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
4
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
6
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year
1996
Number of shared co-authors
9
Andrei Goga
University of California San Francisco
Career Start Year
1993
Number of shared co-authors
5
John Easton
St Jude Children's Research Hospital
Career Start Year
1991
Number of shared co-authors
7
James DeGregori
University of Colorado Anschutz Medical Campus
Career Start Year
1991
Number of shared co-authors
1
Dirk Geerts
Amsterdam University Medical Center
Career Start Year
1989
Number of shared co-authors
0
Poul H Sorensen
British Columbia Cancer Research Centre
Career Start Year
1989
Number of shared co-authors
7
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year
1989
Number of shared co-authors
7
Glenn M Marshall
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year
1989
Number of shared co-authors
5
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year
1989
Number of shared co-authors
15
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
6
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year
1987
Number of shared co-authors
8
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year
1987
Number of shared co-authors
12
Rosalie C Sears
Oregon Health and Science University
Career Start Year
1987
Number of shared co-authors
6
Stefan W??lfl
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
Career Start Year
1987
Number of shared co-authors
0
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year
1984
Number of shared co-authors
7
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1981
Number of shared co-authors
5
David J Adams
Wellcome Sanger Institute
Career Start Year
1980
Number of shared co-authors
7
Roland Nilsson
Karolinska Institutet
Career Start Year
1980
Number of shared co-authors
1
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year
1979
Number of shared co-authors
5
Frank McCormick
Frederick National Laboratory for Cancer Research
Career Start Year
1975
Number of shared co-authors
7
Hartmut Land
University of Rochester Medical Center, Wilmot Cancer Institute
Career Start Year
1974
Number of shared co-authors
1
Norman E Sharpless
National Cancer Institute
Career Start Year
1945
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Karen I Zeller
Co-authored papers
22
Qing Kay Li
Co-authored papers
10
Lewis C Cantley
Co-authored papers
9
Kenneth C Anderson
Dana Farber Cancer Institute
Co-authored papers
9
Elaine R Mardis
The Ohio State University
Co-authored papers
9
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Co-authored papers
8
Massimo Loda
Weill Medical College of Cornell University
Co-authored papers
8
Riccardo Dalla-Favera
Institute for Cancer Genetics, Columbia University
Co-authored papers
7
Jason T Yustein
Co-authored papers
6
Aalim M Weljie
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
6
Linda M S Resar
Johns Hopkins University School of Medicine
Co-authored papers
5
Anil K Sood
The University of Texas MD Anderson Cancer Center
Co-authored papers
5
David W Speicher
Co-authored papers
5
Andrew V Kossenkov
The Wistar Institute
Co-authored papers
5
Seth D Rhoades
University of Pennsylvania
Co-authored papers
4
Kenneth J Cohen
Co-authored papers
4
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Co-authored papers
4
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Co-authored papers
4
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers
4
Linzhao Cheng
Johns Hopkins University School of Medicine
Co-authored papers
3
Peter C Burger
Co-authored papers
3
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Co-authored papers
3
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Co-authored papers
3
Jerry L Spivak
The Johns Hopkins University School of Medicine
Co-authored papers
3
Joshua D Rabinowitz
Lewis Sigler Institute for Integrative Genomics, Princeton University
Co-authored papers
3
Alison R Moliterno
Johns Hopkins Hospital
Co-authored papers
2
Kevan M Shokat
University of California San Francisco
Co-authored papers
2
Richard M Higashi
Co-authored papers
2
John M Maris
Children's Hospital of Philadelphia
Co-authored papers
2
Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers
2
1 - 30